Career & Filing History
Every role John Paulson has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
John Paulson holds the role of Director at Bausch Health Companies Inc. (BHC). Paulson's filing history also covers Acadian Asset Management Inc. (AAMI) and Bausch & Lomb Corp (BLCO). Paulson has reported 18 insider filings with the SEC since 2024. The most recent filing was in July 2026.
Every role John Paulson has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Bausch Health Companies Inc. (BHC)1 filingAcadian Asset Management Inc. (AAMI)1 filingUpdated Aug 31, 2026
John Paulson is Director of Bausch Health Companies Inc. (BHC). 16 SEC Form 4 filings on record going back to 2024, most recently on 2 July 2026. Most recent open-market trade: bought $312.49M of BHC on 15 August 2025. Lifetime open-market purchases: $333.76M. Historical track record: 3/5 stars across 4 tracked purchases.
Every recent SEC Form 4 transaction John Paulson has reported, most recent first.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★☆☆ (3/5) |
| Total purchases tracked | 4 |
| Purchases with forward-return data | 4 |
| 30-day win rate | 75% |
| 90-day win rate | 0% |
| Avg 5-day return | +12.64% |
| Avg 30-day return | +1.95% |
| Avg 90-day return | -6.27% |
| Best 30-day return |
InsiderAlpha's records for John Paulson go back to 2024: 16 primary Form 4 filings, an average of 5.3 per year. The typical open-market purchase is $83.44M (4 buys totaling $333.76M). The largest single buy on record is $312.49M of BHC in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies John Paulson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
John Paulson is a corporate insider, tracked as Director of Bausch Health Companies Inc. (BHC). InsiderAlpha holds 16 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 4 open-market purchases ($333.76M) and 0 open-market sales across all tracked filings.
Across 4 tracked purchases, John Paulson averaged +1.9% avg 30-day return with a 75% 30-day win rate. InsiderAlpha rates the track record at 3/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$BHC Bausch Health Companies Inc.45.9K shares @ $0.00-
| +7.36% |